Partners

At Biomir, we offer new possibilities for collaboration and innovation with various partners. we understand that business partnerships can help us achieve mutual goals of developing and delivering innovative new products to improve consumer health and patient care. We are well-positioned as a partner of choice given our financial strength, significant partnership network, proven track record for improving market access to novel treatment and strategies and commercial expertise in the pharmaceutical, Medical Technology, Consumer Health, Animal Health and Crop Science markets. As we look ahead, we remain committed to collaborations with like-minded partners who share our commitment in the discovery, development, and commercialization of innovative products.

Thompson Oncology Devices LLC

Thompson Oncology and the UNLEASH® Device Thompson Oncology Devices LLC was formed in 2018 to advance the immunotherapy device invented by Mark D. Howell, Ph.D., at Colorado State University in Fort Collins. With support from CSU Research Foundation, Dr. Howell’s discoveries led to the UNLEASH® technology, a powerful experimental tool that represents a new approach to treating a wide spectrum of cancerous tumors. The extracorporeal device effectively up-regulates immune system signaling molecule.

Biomir proudly announces a groundbreaking collaboration with Thompson Oncology Devices LLC, a pioneer in revolutionizing cancer treatment through cutting-edge technology. At the forefront of this partnership lies the UNLEASH® Device, an extraordinary innovation born from the visionary work of Dr. Mark D. Howell, Ph.D., at Colorado State University. Developed with the unwavering support of the CSU Research Foundation, the UNLEASH® technology stands as a beacon of hope in the realm of immunotherapy.